COURTNEY KINHOLT: Open Payments
NPI 1194460709 · IRVINE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$645 in 27 payments from 14 companies in 2025. Trend: 2023 $779 · 2024 $2,590 · 2025 $645
Food & beverage: $645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $167 |
| Novartis Pharmaceuticals Corporation | 3 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| SOBI, INC | 1 | $44 |
| Aveo Pharmaceuticals, Inc. | 1 | $36 |
| TerSera Therapeutics LLC | 1 | $32 |
| Lilly USA, LLC | 1 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $29 |
Products named: VRAYLAR, KISQALI, Nubeqa, KEYTRUDA, Doptelet, EPKINLY, FOTIVDA, Zoladex.
Industry payments across CA — which companies pay providers there.
